Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:businessModel |
biopharmaceuticals
|
| gptkbp:country |
gptkb:Sweden
|
| gptkbp:founded |
1999
|
| gptkbp:headquarters_location |
gptkb:Södertälje
|
| https://www.w3.org/2000/01/rdf-schema#label |
AstraZeneca AB
|
| gptkbp:industry |
gptkb:drug
|
| gptkbp:languageOfWork |
Swedish
|
| gptkbp:legalForm |
aktiebolag
|
| gptkbp:located_in_administrative_territorial_entity |
gptkb:Stockholm_County
|
| gptkbp:notableProduct |
gptkb:Nexium
gptkb:Brilinta gptkb:Crestor gptkb:Symbicort gptkb:Tagrisso vaccine |
| gptkbp:numberOfEmployees |
approximately 7,000 (Sweden, 2023)
|
| gptkbp:officialWebsite |
https://www.astrazeneca.se/
|
| gptkbp:parentOrganization |
gptkb:AstraZeneca_plc
|
| gptkbp:part_of |
gptkb:AstraZeneca_Group
|
| gptkbp:subsidiary |
gptkb:AstraZeneca_plc
|
| gptkbp:bfsParent |
gptkb:AstraZeneca
|
| gptkbp:bfsLayer |
5
|